Biogen Inc
NASDAQ: BIIB
$199.36
-$2.08 (-1.0%)
Closing Price on September 20, 2024
BIIB Articles
The November 30 short interest data have been compared with the previous report, and short interest was mixed in these selected stocks for this settlement date.
Published:
Last Updated:
24/7 Wall St. has reviewed the short interest data on the top biotech companies.
Published:
Last Updated:
The short interest data are out for the October 30 settlement date, and short interest fell in selected biotech stocks.
Published:
Last Updated:
As we are just about through with the spooky month on Wall Street, and the third-quarter earnings are starting to wrap up, one thing we are seeing here is an increase in overall insider activity.
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and short interest mixed in these selected biotech stocks.
Published:
Biogen reported better-than-expected third-quarter financial results Wednesday before the market opened.
Published:
24/7 Wall St. has put together a preview of GM, Yahoo and some of the major companies reporting their quarterly results this week.
Published:
Last Updated:
These three top biotech names are very good bets for investors looking to add high-quality companies with less volatility and binary clinical data risk.
Published:
ThinkstockOctober 12, 2015: Here are four stocks trading with heavy volume among 25 equities making new 52-week lows today. VMware Inc. (NYSE: VMW) dropped more than 11% on Monday to post a new...
Published:
Last Updated:
The September 30 short interest data have been compared with the previous figures, and short interest increased in most of these selected biotech stocks for this settlement date.
Published:
24/7 Wall St. has taken a look at some of the largest biotech companies and highlighted the damage that a single tweet did to them last week.
Published:
The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks increased across the board for this settlement date.
Published:
In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.
Published:
The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased across the board for this settlement date.
Published:
ThinkstockAre biotech companies going to become the next big companies saddled with debt? Most likely not, but two debt offerings will stand out to investors here. The first was a $10 billion...
Published: